IonMAN II Trial- Early Feasibility Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System
NCT: NCT06071702 · SUSPENDED
広告
NCT識別子NCT06071702
ステータスSUSPENDED
開始日2025-08-07
完了2026-12-07
SponsorMedinol Ltd. (INDUSTRY)
First posted
Last updated
概要
This is a prospective, multi-center, single-arm, open-label, early feasibility study to provide preliminary evidence for the safety and efficacy of the novel IoNIR stent system
公式ソース
ClinicalTrials.govで見る →データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。